Authors:
Rebecca Feldman Ph.D. , Gargi Basu Ph.D. , Joanne Xiu Ph.D. , David Arguello M.D. , Sherri Z. Millis Ph.D. , Ryan Bender Ph.D. , Zoran Gatalica M.D. , Les Paul M.D. , Charles Myers M.D
Background: Prostate cancer is the second leading cause of cancer‐related death among men in the US. Forty percent of men diagnosed will develop metastatic disease which has few treatment options. We aim to describe the molecular profile of prostate cancer tumors and potential for novel therapeutic options.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |